Pharmacy Practice and Science Department Highlights: October 2018


Ex Ante economic evaluation of genetic testing for the ARG389 beta1-adrenergic receptor polymorphism to support bucindolol treatment decisions in stage III/IV heart failure. Expert Rev Precis Med Drug Dev. 2018 [In Press]

Economic evaluation for the UK of systemic chemotherapies as first-line treatment of metastatic pancreatic cancer. PharmacoEconomica 36:1333-1343, 2018 

Pharmacy competencies for interprofessional integrative healthcare education. Am J Pharm Educ. 2018;82(6): Article 6302. 

User Insights for Design of an Antihypertensive Medication Management Application. Proceedings of the 2018 Human Factors and Ergonomics Society Annual Meeting. 2018 October:1077-1081. doi: 10.1177/1541931218621247. 


Maryam Fazel, PharmD, BCPS, BCACP, CDE

  • “External validation and comparison of two 30-day readmission prediction models in patients with diabetes.” ACCP Global Conference; 2018 October 20-23; Seattle, WA.

Jason H. Karnes, PharmD, PhD, BCPS, FAHA

  • “Pharmacogenomics in Cardiovascular Medicine: Minimizing Racial Disparities while Improving Drug Safety and Efficacy.” Western Medicaid Pharmacy Administrators Association 2018 Annual Meeting, Tucson, AZ
  • “Pharmacogenomics of Vasodilator Response in Pulmonary Arterial Hypertension.” Pharmacogenomics Research Network Research in Progress Seminar (PGRN-RIPS)

Jeannie Lee, PharmD, BCPS, CGP, FASHP

  • “Medication Management” presented as part of the Aging Mastery Program® - Pima Council on Aging and Resurrection Lutheran Church, Oro Valley, AZ. October 2018

Poster Presentation

Use of Melatonin Receptor Agonists for the Treatment of Insomnia in Older Adults: A Systematic Review and Meta-Analysis. American College of Clinical Pharmacy (ACCP) Global Conference on Clinical Pharmacy, Seattle, WA. October 2018.


Hanna Phan, PharmD, FCCP, FPPAG

  • Dr. Phan has been appointed Assistant Department Head for Pharmacy Practice and Science.

Jason H. Karnes, PharmD, PhD, BCPS, FAHA

  • Dr. Karnes has been elected Fellow of the American Heart Association by the American Heart Association’s Genomic and Precision Medicine Council
  • Dr. Karnes received a grant from the Flinn Foundation for $200,000 titled Seed Grant to Promote Translational Research in Precision Medicine - Large-Scale Implementation of Pharmacogenomics: Translating Genotype-Guided Warfarin Dosing from Discovery to the Bedside